Intercure(INCR)

2.4219 -0.028 -1.14%

今开:2.43昨收:2.45
最高:2.43 最低:2.41
涨停价:0.0跌停价:0.0
总市值:1.10372495E8

Intercure的热门讨论

逍遥投资派2023-05-21 22:59

$Intercure(INCR)$ 2021年上市以来营收高速增长,营业利润和净利润增速也非常快,只是在最近一个季度(2022Q4)营业利润转亏,主要受毛利率大幅下滑和管理费用大幅提升影响。
2022年利息费用占营业利润的34%,负担很重。
2022年有0.17亿的其他净收入,如果不考虑的话相对于2021年并没有增...查看全文

财报披露

Intercure(INCR)04-01 20:45

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-012171  Act: 34  Size: 63 KB 网页链接查看全文

财报披露

Intercure(INCR)02-14 06:05

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-006162  Act: 34  Size: 33 KB 网页链接查看全文

财报披露

Intercure(INCR)02-14 05:35

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-006100  Act: 34  Size: 15 KB 网页链接查看全文

财报披露

Intercure(INCR)01-31 22:05

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-004419  Act: 34  Size: 52 KB 网页链接查看全文

财报披露

Intercure(INCR)2023-12-15 05:35

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-044868  Act: 34  Size: 17 KB 网页链接查看全文

财报披露

Intercure(INCR)2023-11-09 05:35

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-039914  Act: 34  Size: 159 KB 网页链接查看全文

财报披露

Intercure(INCR)2023-11-01 04:55

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-038872  Act: 34  Size: 60 KB 网页链接查看全文

财报披露

Intercure(INCR)2023-10-18 05:25

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-037528  Act: 34  Size: 45 KB 网页链接查看全文

财报披露

Intercure(INCR)2023-08-15 04:35

$Intercure(INCR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-23-028524  Act: 34  Size: 17 KB 网页链接查看全文

1 2 3 4 5 6

Intercure的最新讨论

逍遥投资派2023-05-21 22:59

$Intercure(INCR)$ 2021年上市以来营收高速增长,营业利润和净利润增速也非常快,只是在最近一个季度(2022Q4)营业利润转亏,主要受毛利率大幅下滑和管理费用大幅提升影响。
2022年利息费用占营业利润的34%,负担很重。
2022年有0.17亿的其他净收入,如果不考虑的话相对于2021年并没有增...查看全文

资本主义拉美行不通2017-05-10 19:23

$INC Research Holdings(INCR)$收购$inVentiv Health(VTIV)$的交易太棒了,几乎不用增加负债,哈哈哈哈!!昆泰你颤抖了吗?查看全文

胖猴围脖2016-10-31 22:15

$INC Research Holdings(INCR)$ 财报很不错,$昆泰医药(Q)$$查尔斯河(CRL)$ 估计也不会太差吧[加油]查看全文

步步_为赢2016-04-19 09:52

$INC Research Holdings(INCR)$ 这货是在冲顶吗。49->57->49查看全文

我是_一级棒2016-04-19 07:51

$INC Research Holdings(INCR)$ 公司新产品.... 要冲新高了。查看全文

Pnmk2015-04-28 03:24

$INC Research Holdings(INCR)$ $PRA Health Sciences(PRAH)$ 两个类似的公司。INCR大涨查看全文

Intercure的公告

$INC Research Holdings(INCR)$ 内部交易: 2016-09-27,CEO,Macdonald D. Jamie ,卖出,53970普通股, $44.30

$INC Research Holdings(INCR)$ 内部交易: 2016-09-27,CEO,Macdonald D. Jamie ,期权,36688普通股, $14.83

$INC Research Holdings(INCR)$ 内部交易: 2016-09-26,Director,Breckon Robert W ,卖出,12197普通股, $44.16

$INC Research Holdings(INCR)$ 内部交易: 2016-09-26,Director,Breckon Robert W ,期权,7600普通股, $8.45

$INC Research Holdings(INCR)$ 内部交易: 2016-09-19,Director,Burgstahler David F ,买入,1000普通股, $43.19

$INC Research Holdings(INCR)$ 内部交易: 2016-09-14,CAO, GC & Sec,Gaenzle Christopher L ,卖出,4734普通股, $43.14

$INC Research Holdings(INCR)$ 内部交易: 2016-09-14,CAO, GC & Sec,Gaenzle Christopher L ,期权,4734普通股, $10.06

$INC Research Holdings(INCR)$ 8-K - Current report Filed: 2016-09-15 AccNo: 0001193125-16-710419 Size: 129 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: ...

$INC Research Holdings(INCR)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-09-12 AccNo: 0000932471-16-014442 Size: 34 KB 网页链接

$INC Research Holdings(INCR)$ 8-K - Current report Filed: 2016-08-31 AccNo: 0001610950-16-000053 Size: 210 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29